Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 274.39B | 222.43B | 210.81B | 133.82B | 91.31B |
Gross Profit | 73.36B | 69.86B | 72.08B | 48.68B | 30.78B |
EBITDA | 51.63B | 44.59B | 47.85B | 30.76B | 18.82B |
Net Income | 15.69B | 15.15B | 29.70B | 26.66B | 8.28B |
Balance Sheet | |||||
Total Assets | 600.59B | 510.03B | 410.65B | 264.77B | 177.19B |
Cash, Cash Equivalents and Short-Term Investments | 117.73B | 117.25B | 103.11B | 52.58B | 30.20B |
Total Debt | 168.28B | 140.85B | 72.26B | 39.52B | 49.77B |
Total Liabilities | 277.04B | 231.86B | 161.00B | 103.82B | 98.95B |
Stockholders Equity | 236.83B | 204.41B | 183.77B | 131.07B | 67.18B |
Cash Flow | |||||
Free Cash Flow | -25.17B | -46.51B | -13.95B | -15.99B | -1.08B |
Operating Cash Flow | 26.07B | 28.72B | 43.02B | 17.83B | 13.22B |
Investing Cash Flow | -36.63B | -92.40B | -68.76B | -29.40B | -20.88B |
Financing Cash Flow | 15.97B | 55.24B | 68.72B | 30.60B | 21.69B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥152.43B | 16.93 | 2.24% | 9.00% | -50.84% | ||
80 Outperform | ¥82.04B | 8.72 | 1.13% | 11.53% | 20.33% | ||
77 Outperform | ¥180.10B | 11.19 | 7.01% | 3.68% | 23.36% | 3.61% | |
72 Outperform | ¥171.27B | 17.51 | 3.26% | 18.61% | 30.56% | ||
67 Neutral | ¥210.53B | 4.13 | 0.38% | -48.30% | ― | ||
57 Neutral | HK$14.57B | 5.76 | -5.77% | 4.75% | 9.65% | -43.80% |